Replies to post #174475 on Biotech Values

[GrthzGd]

b) The unlimited downside risk is a mirage. Market caps just don't go to infinity. Basically risk of being short is about the same as being long.

Not so much in a small biotech that can shoot up quite high IMO. I also don't like the idea of being forced into something by external market conditions, which is also why I don't buy on margin--to your point about timing, I think.

[linhdtu]

Peter, how does your logic work in the case of ICPT ?

Before the blast off, ICPT was 70 then it went all the way to 450.

Now if I was an ICPT short, it would be too much to assume that I could short say 1K sh, costing me 35K$ to lay down the short.

I would have lost my shirt when it went to 450/sh. So the argument about the short loss not being unlimited is moot or relevant in this case, no ?
-----
The unlimited downside risk is a mirage. Market caps just don't go to infinity. Basically risk of being short is about the same as being long.
-----